blp 1654 has been researched along with Gram-Negative Bacterial Infections in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bodey, GP; Horikoshi, N; Rodriguez, V | 1 |
1 trial(s) available for blp 1654 and Gram-Negative Bacterial Infections
Article | Year |
---|---|
Human pharmacology of 6-[D-alpha-(3-guanylureido)-phenylacetamido]-penicillanic acid (BL-P1654).
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Gram-Negative Bacterial Infections; Humans; Middle Aged; Neoplasms; Penicillanic Acid | 1974 |